▶ 調査レポート

腫瘍用注射薬の世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Oncology Injection Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。腫瘍用注射薬の世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Oncology Injection Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-11450資料のイメージです。• レポートコード:D005-11450
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:化学・材料
• 販売価格(消費税別)
  Single User¥379,320 (USD3,480)▷ お問い合わせ
  Multi User¥568,980 (USD5,220)▷ お問い合わせ
  Corporate User¥758,640 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、腫瘍用注射薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。腫瘍用注射薬の種類別市場規模(臓器、中枢神経系、循環器/筋骨格系)、用途別市場規模(リンパ腫、骨髄腫、前立腺癌)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Taj Oncology、Genzyme、Merrimack、S.G. Biopharm、Ferring Pharmaceuticals、AdvaCare、Praecis Pharmaceuticals、Allos Therapeutics、Celgene、Eli Lilly、Pharmascience、Millennium Pharmaceuticals、CordenPharma、Debiopharm、Alza
・地域別グローバル市場分析 2015年-2020年
・腫瘍用注射薬の北米市場(アメリカ、カナダ、メキシコ)
・腫瘍用注射薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・腫瘍用注射薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・腫瘍用注射薬の南米市場(ブラジル、アルゼンチン)
・腫瘍用注射薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:臓器、中枢神経系、循環器/筋骨格系
・用途別分析:リンパ腫、骨髄腫、前立腺癌
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Oncology Injection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Oncology Injection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Oncology Injection Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oncology Injection Drug market has been segmented into
Organs
Central Nervous System
Circulatory/Musculoskeletal System

By Application, Oncology Injection Drug has been segmented into:
Lymphoma
Myeloma
Prostate Cancer

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Injection Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Injection Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Injection Drug market.

The report offers in-depth assessment of the growth and other aspects of the Oncology Injection Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Oncology Injection Drug Market Share Analysis
Oncology Injection Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncology Injection Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Injection Drug sales, revenue and market share for each player covered in this report.

The major players covered in Oncology Injection Drug are:
Taj Oncology
Genzyme
Merrimack
S.G. Biopharm
Ferring Pharmaceuticals
AdvaCare
Praecis Pharmaceuticals
Allos Therapeutics
Celgene
Eli Lilly
Pharmascience
Millennium Pharmaceuticals
CordenPharma
Debiopharm
Alza

Among other players domestic and global, Oncology Injection Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology Injection Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Injection Drug, with price, sales, revenue and global market share of Oncology Injection Drug in 2018 and 2019.
Chapter 3, the Oncology Injection Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Injection Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Oncology Injection Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Oncology Injection Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Oncology Injection Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Injection Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Injection Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.4 Overview of Global Oncology Injection Drug Market
1.4.1 Global Oncology Injection Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Taj Oncology
2.1.1 Taj Oncology Details
2.1.2 Taj Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Taj Oncology SWOT Analysis
2.1.4 Taj Oncology Product and Services
2.1.5 Taj Oncology Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genzyme
2.2.1 Genzyme Details
2.2.2 Genzyme Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genzyme SWOT Analysis
2.2.4 Genzyme Product and Services
2.2.5 Genzyme Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merrimack
2.3.1 Merrimack Details
2.3.2 Merrimack Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merrimack SWOT Analysis
2.3.4 Merrimack Product and Services
2.3.5 Merrimack Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 S.G. Biopharm
2.4.1 S.G. Biopharm Details
2.4.2 S.G. Biopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 S.G. Biopharm SWOT Analysis
2.4.4 S.G. Biopharm Product and Services
2.4.5 S.G. Biopharm Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ferring Pharmaceuticals
2.5.1 Ferring Pharmaceuticals Details
2.5.2 Ferring Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ferring Pharmaceuticals SWOT Analysis
2.5.4 Ferring Pharmaceuticals Product and Services
2.5.5 Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AdvaCare
2.6.1 AdvaCare Details
2.6.2 AdvaCare Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AdvaCare SWOT Analysis
2.6.4 AdvaCare Product and Services
2.6.5 AdvaCare Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Praecis Pharmaceuticals
2.7.1 Praecis Pharmaceuticals Details
2.7.2 Praecis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Praecis Pharmaceuticals SWOT Analysis
2.7.4 Praecis Pharmaceuticals Product and Services
2.7.5 Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allos Therapeutics
2.8.1 Allos Therapeutics Details
2.8.2 Allos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allos Therapeutics SWOT Analysis
2.8.4 Allos Therapeutics Product and Services
2.8.5 Allos Therapeutics Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Celgene
2.9.1 Celgene Details
2.9.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Celgene SWOT Analysis
2.9.4 Celgene Product and Services
2.9.5 Celgene Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly SWOT Analysis
2.10.4 Eli Lilly Product and Services
2.10.5 Eli Lilly Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pharmascience
2.11.1 Pharmascience Details
2.11.2 Pharmascience Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pharmascience SWOT Analysis
2.11.4 Pharmascience Product and Services
2.11.5 Pharmascience Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Millennium Pharmaceuticals
2.12.1 Millennium Pharmaceuticals Details
2.12.2 Millennium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Millennium Pharmaceuticals SWOT Analysis
2.12.4 Millennium Pharmaceuticals Product and Services
2.12.5 Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 CordenPharma
2.13.1 CordenPharma Details
2.13.2 CordenPharma Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 CordenPharma SWOT Analysis
2.13.4 CordenPharma Product and Services
2.13.5 CordenPharma Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Debiopharm
2.14.1 Debiopharm Details
2.14.2 Debiopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Debiopharm SWOT Analysis
2.14.4 Debiopharm Product and Services
2.14.5 Debiopharm Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Alza
2.15.1 Alza Details
2.15.2 Alza Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Alza SWOT Analysis
2.15.4 Alza Product and Services
2.15.5 Alza Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Oncology Injection Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Oncology Injection Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology Injection Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Oncology Injection Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Oncology Injection Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology Injection Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oncology Injection Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Oncology Injection Drug Sales and Growth Rate (2015-2020)
4.3 Europe Oncology Injection Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncology Injection Drug Sales and Growth Rate (2015-2020)
4.5 South America Oncology Injection Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Oncology Injection Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Oncology Injection Drug Sales, Revenue and Market Share by Country
5.1.1 North America Oncology Injection Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Oncology Injection Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Oncology Injection Drug Sales and Growth Rate (2015-2020)
5.3 Canada Oncology Injection Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Oncology Injection Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Oncology Injection Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Oncology Injection Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Oncology Injection Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Oncology Injection Drug Sales and Growth Rate (2015-2020)
6.3 UK Oncology Injection Drug Sales and Growth Rate (2015-2020)
6.4 France Oncology Injection Drug Sales and Growth Rate (2015-2020)
6.5 Russia Oncology Injection Drug Sales and Growth Rate (2015-2020)
6.6 Italy Oncology Injection Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oncology Injection Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Oncology Injection Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Oncology Injection Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Oncology Injection Drug Sales and Growth Rate (2015-2020)
7.3 Japan Oncology Injection Drug Sales and Growth Rate (2015-2020)
7.4 Korea Oncology Injection Drug Sales and Growth Rate (2015-2020)
7.5 India Oncology Injection Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Oncology Injection Drug Sales and Growth Rate (2015-2020)
7.7 Australia Oncology Injection Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Oncology Injection Drug Sales, Revenue and Market Share by Country
8.1.1 South America Oncology Injection Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Oncology Injection Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Oncology Injection Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Oncology Injection Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oncology Injection Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Oncology Injection Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Oncology Injection Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Oncology Injection Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Oncology Injection Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Oncology Injection Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Oncology Injection Drug Sales and Market Share by Type (2015-2020)
10.2 Global Oncology Injection Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Oncology Injection Drug Price by Type (2015-2020)
11 Global Oncology Injection Drug Market Segment by Application
11.1 Global Oncology Injection Drug Sales Market Share by Application (2015-2020)
11.2 Global Oncology Injection Drug Revenue Market Share by Application (2015-2020)
11.3 Global Oncology Injection Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Oncology Injection Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Oncology Injection Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Oncology Injection Drug Market Forecast (2021-2025)
12.2.2 Europe Oncology Injection Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Oncology Injection Drug Market Forecast (2021-2025)
12.2.4 South America Oncology Injection Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Oncology Injection Drug Market Forecast (2021-2025)
12.3 Oncology Injection Drug Market Forecast by Type (2021-2025)
12.3.1 Global Oncology Injection Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Oncology Injection Drug Market Share Forecast by Type (2021-2025)
12.4 Oncology Injection Drug Market Forecast by Application (2021-2025)
12.4.1 Global Oncology Injection Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Oncology Injection Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Oncology Injection Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Injection Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Injection Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Taj Oncology Basic Information, Manufacturing Base and Competitors
Table 8. Taj Oncology Oncology Injection Drug Major Business
Table 9. Taj Oncology Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 10. Taj Oncology SWOT Analysis
Table 11. Taj Oncology Oncology Injection Drug Product and Services
Table 12. Taj Oncology Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Genzyme Basic Information, Manufacturing Base and Competitors
Table 14. Genzyme Oncology Injection Drug Major Business
Table 15. Genzyme Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 16. Genzyme SWOT Analysis
Table 17. Genzyme Oncology Injection Drug Product and Services
Table 18. Genzyme Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Merrimack Basic Information, Manufacturing Base and Competitors
Table 20. Merrimack Oncology Injection Drug Major Business
Table 21. Merrimack Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 22. Merrimack SWOT Analysis
Table 23. Merrimack Oncology Injection Drug Product and Services
Table 24. Merrimack Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. S.G. Biopharm Basic Information, Manufacturing Base and Competitors
Table 26. S.G. Biopharm Oncology Injection Drug Major Business
Table 27. S.G. Biopharm Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 28. S.G. Biopharm SWOT Analysis
Table 29. S.G. Biopharm Oncology Injection Drug Product and Services
Table 30. S.G. Biopharm Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Ferring Pharmaceuticals Oncology Injection Drug Major Business
Table 33. Ferring Pharmaceuticals Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 34. Ferring Pharmaceuticals SWOT Analysis
Table 35. Ferring Pharmaceuticals Oncology Injection Drug Product and Services
Table 36. Ferring Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AdvaCare Basic Information, Manufacturing Base and Competitors
Table 38. AdvaCare Oncology Injection Drug Major Business
Table 39. AdvaCare Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 40. AdvaCare SWOT Analysis
Table 41. AdvaCare Oncology Injection Drug Product and Services
Table 42. AdvaCare Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Praecis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Praecis Pharmaceuticals Oncology Injection Drug Major Business
Table 45. Praecis Pharmaceuticals Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 46. Praecis Pharmaceuticals SWOT Analysis
Table 47. Praecis Pharmaceuticals Oncology Injection Drug Product and Services
Table 48. Praecis Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Allos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 50. Allos Therapeutics Oncology Injection Drug Major Business
Table 51. Allos Therapeutics Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 52. Allos Therapeutics SWOT Analysis
Table 53. Allos Therapeutics Oncology Injection Drug Product and Services
Table 54. Allos Therapeutics Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Celgene Basic Information, Manufacturing Base and Competitors
Table 56. Celgene Oncology Injection Drug Major Business
Table 57. Celgene Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 58. Celgene SWOT Analysis
Table 59. Celgene Oncology Injection Drug Product and Services
Table 60. Celgene Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 62. Eli Lilly Oncology Injection Drug Major Business
Table 63. Eli Lilly Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 64. Eli Lilly SWOT Analysis
Table 65. Eli Lilly Oncology Injection Drug Product and Services
Table 66. Eli Lilly Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pharmascience Basic Information, Manufacturing Base and Competitors
Table 68. Pharmascience Oncology Injection Drug Major Business
Table 69. Pharmascience Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 70. Pharmascience SWOT Analysis
Table 71. Pharmascience Oncology Injection Drug Product and Services
Table 72. Pharmascience Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Millennium Pharmaceuticals Oncology Injection Drug Major Business
Table 75. Millennium Pharmaceuticals Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 76. Millennium Pharmaceuticals SWOT Analysis
Table 77. Millennium Pharmaceuticals Oncology Injection Drug Product and Services
Table 78. Millennium Pharmaceuticals Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 80. CordenPharma Oncology Injection Drug Major Business
Table 81. CordenPharma Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 82. CordenPharma SWOT Analysis
Table 83. CordenPharma Oncology Injection Drug Product and Services
Table 84. CordenPharma Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Debiopharm Basic Information, Manufacturing Base and Competitors
Table 86. Debiopharm Oncology Injection Drug Major Business
Table 87. Debiopharm Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 88. Debiopharm SWOT Analysis
Table 89. Debiopharm Oncology Injection Drug Product and Services
Table 90. Debiopharm Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Alza Basic Information, Manufacturing Base and Competitors
Table 92. Alza Oncology Injection Drug Major Business
Table 93. Alza Oncology Injection Drug Total Revenue (USD Million) (2018-2019)
Table 94. Alza SWOT Analysis
Table 95. Alza Oncology Injection Drug Product and Services
Table 96. Alza Oncology Injection Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Oncology Injection Drug Sales by Manufacturer (2018-2019) (MT)
Table 98. Global Oncology Injection Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Oncology Injection Drug Sales by Regions (2015-2020) (MT)
Table 100. Global Oncology Injection Drug Sales Market Share by Regions (2015-2020)
Table 101. Global Oncology Injection Drug Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Oncology Injection Drug Sales by Countries (2015-2020) (MT)
Table 103. North America Oncology Injection Drug Sales Market Share by Countries (2015-2020)
Table 104. North America Oncology Injection Drug Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Oncology Injection Drug Revenue Market Share by Countries (2015-2020)
Table 106. Europe Oncology Injection Drug Sales by Countries (2015-2020) (MT)
Table 107. Europe Oncology Injection Drug Sales Market Share by Countries (2015-2020)
Table 108. Europe Oncology Injection Drug Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Oncology Injection Drug Sales by Regions (2015-2020) (MT)
Table 110. Asia-Pacific Oncology Injection Drug Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Oncology Injection Drug Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Oncology Injection Drug Sales by Countries (2015-2020) (MT)
Table 113. South America Oncology Injection Drug Sales Market Share by Countries (2015-2020)
Table 114. South America Oncology Injection Drug Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Oncology Injection Drug Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Oncology Injection Drug Sales by Countries (2015-2020) (MT)
Table 117. Middle East & Africa Oncology Injection Drug Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Oncology Injection Drug Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Oncology Injection Drug Revenue Market Share by Countries (2015-2020)
Table 120. Global Oncology Injection Drug Sales by Type (2015-2020) (MT)
Table 121. Global Oncology Injection Drug Sales Share by Type (2015-2020)
Table 122. Global Oncology Injection Drug Revenue by Type (2015-2020) (USD Million)
Table 123. Global Oncology Injection Drug Revenue Share by Type (2015-2020)
Table 124. Global Oncology Injection Drug Sales by Application (2015-2020) (MT)
Table 125. Global Oncology Injection Drug Sales Share by Application (2015-2020)
Table 126. Global Oncology Injection Drug Sales Forecast by Regions (2021-2025) (MT)
Table 127. Global Oncology Injection Drug Market Share Forecast by Regions (2021-2025)
Table 128. Global Oncology Injection Drug Sales Forecast by Type (2021-2025) (MT)
Table 129. Global Oncology Injection Drug Market Share Forecast by Type (2021-2025)
Table 130. Global Oncology Injection Drug Sales Forecast by Application (2021-2025)
Table 131. Global Oncology Injection Drug Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Oncology Injection Drug Picture
Figure 2. Global Sales Market Share of Oncology Injection Drug by Type in 2019
Figure 3. Organs Picture
Figure 4. Central Nervous System Picture
Figure 5. Circulatory/Musculoskeletal System Picture
Figure 6. Oncology Injection Drug Sales Market Share by Application in 2018
Figure 7. Lymphoma Picture
Figure 8. Myeloma Picture
Figure 9. Prostate Cancer Picture
Figure 10. Global Oncology Injection Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Oncology Injection Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Oncology Injection Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Oncology Injection Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Oncology Injection Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Oncology Injection Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Oncology Injection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Oncology Injection Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Oncology Injection Drug Revenue Market Share by Regions in 2018
Figure 39. North America Oncology Injection Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Oncology Injection Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Oncology Injection Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Oncology Injection Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Oncology Injection Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Oncology Injection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Oncology Injection Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Oncology Injection Drug Sales Market Share by Countries in 2018
Figure 47. North America Oncology Injection Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Oncology Injection Drug Revenue Market Share by Countries in 2018
Figure 49. United States Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Oncology Injection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Oncology Injection Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Oncology Injection Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Oncology Injection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Oncology Injection Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Oncology Injection Drug Revenue Market Share by Regions 2019
Figure 63. China Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Oncology Injection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Oncology Injection Drug Sales Market Share by Countries in 2019
Figure 70. South America Oncology Injection Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Oncology Injection Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Oncology Injection Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Oncology Injection Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Oncology Injection Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Oncology Injection Drug Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Oncology Injection Drug Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Oncology Injection Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Oncology Injection Drug Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Oncology Injection Drug Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Oncology Injection Drug Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Oncology Injection Drug Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Oncology Injection Drug Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel